ANIP

ANI Pharmaceuticals, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD83.55

-0.57 (-0.67%)

Rating:B

Company Profile

CEO

Nikhil Lalwani

IPO Date

2000-05-05

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

Market Metrics

Open

$84.12

Prev. Close

$84.11

Day Low

$82.86

Day High

$84.12

52W Low

$62.61

52W High

$99.50

Market Cap

$1.90B

Volume

0.05M

News SentimentBullish

Articles

Avg Positive

38.7%

Avg Negative

3.4%

Avg Neutral

57.9%

News Feed

ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome

Business Wire·8/31/2021·↑ positive

ANI Pharmaceuticals' (ANIP) CEO Nikhil Lalwani on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/6/2021·↓ negative